Stay updated on Lemzoparlimab Combination in MDS Clinical Trial
Sign up to get notified when there's something new on the Lemzoparlimab Combination in MDS Clinical Trial page.

Latest updates to the Lemzoparlimab Combination in MDS Clinical Trial page
- Check4 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check11 days agoChange DetectedA notice announces NIH website updates and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference0.8%

- Check18 days agoChange DetectedThe site’s footer revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check25 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check46 days agoChange DetectedAn updated revision entry (v3.7.0) was added to the study history, superseding the previous revision (v3.6.6). This indicates a newer version of the study record has been published.SummaryDifference0.1%

- Check67 days agoChange DetectedThe record history now shows Revision: v3.6.6 as the latest release, and the previous Revision: v3.6.5 entry has been removed. This reflects an underlying platform update displayed in the study's version history.SummaryDifference0.1%

Stay in the know with updates to Lemzoparlimab Combination in MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lemzoparlimab Combination in MDS Clinical Trial page.